AI
Big Pharma's AI bet comes with fine print
Eli Lilly's $2.75 billion deal with AI drug startup Insilico Medicine is mostly contingent on milestones, since no AI-discovered drug has cleared FDA approval yet.
Saira Mueller is a senior culture and technology editor who's spent the last decade exploring how digital life rewires our workdays, our brains, and occasionally our love lives. Before joining Morning Brew, she wrote and edited for WIRED, CNN, and Vox Media, covering everything from video games to big tech and the strange ways digital habits spill into the real world. When she's not interrogating the future of tech, she's usually powering through an audiobook while walking her dog, Asteria, or trying to convince her friends to go see yet another Broadway show with her. She's Australian and German, is based in New York, and firmly believes that the best tech stories are really people stories wearing slightly nerdier outfits.
Tech Business
The never-ending year of efficiency
The new equation across Big Tech is: fewer people, more compute.
AI
Grok’s paywall can't hide its deepfake problem
After a flood of nonconsensual deepfakes on X, Grok restricted image generation to paying subscribers. People found simple workarounds within hours.
Tech
Welcome to the new Tech Brew
Something new is brewing.
Big Tech